Folgen
Catherine Le Berre
Catherine Le Berre
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei leberre.org
Titel
Zitiert von
Zitiert von
Jahr
Application of artificial intelligence to gastroenterology and hepatology
C Le Berre, WJ Sandborn, S Aridhi, MD Devignes, L Fournier, ...
Gastroenterology 158 (1), 76-94. e2, 2020
3892020
Newer biologic and small-molecule therapies for inflammatory bowel disease
DC Baumgart, C Le Berre
New England Journal of Medicine 385 (14), 1302-1315, 2021
1572021
Ulcerative colitis and Crohn’s disease have similar burden and goals for treatment
C Le Berre, AN Ananthakrishnan, S Danese, S Singh, L Peyrin-Biroulet
Clinical Gastroenterology and Hepatology 18 (1), 14-23, 2020
1252020
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?
S Danese, M Argollo, C Le Berre, L Peyrin-Biroulet
Gut 68 (10), 1893-1899, 2019
1182019
Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD
C Le Berre, L Peyrin-Biroulet, WJ Sandborn, JF Colombel, D Rubin, ...
Gastroenterology 160 (5), 1452-1460. e21, 2021
852021
Modern use of 5-aminosalicylic acid compounds for ulcerative colitis
C Le Berre, G Roda, M Nedeljkovic Protic, S Danese, L Peyrin-Biroulet
Expert Opinion on Biological Therapy 20 (4), 363-378, 2020
792020
Vedolizumab treatment in extra-intestinal manifestations in inflammatory bowel disease: a systematic review
T Chateau, S Bonovas, C Le Berre, N Mathieu, S Danese, ...
Journal of Crohn's and Colitis 13 (12), 1569-1577, 2019
462019
Small bowel capsule endoscopy and treat-to-target in Crohn's disease: a systematic review
C Le Berre, C Trang-Poisson, A Bourreille
World Journal of Gastroenterology 25 (31), 4534, 2019
412019
Combination therapy with vedolizumab and tofacitinib in a patient with ulcerative colitis and spondyloarthropathy
C Le Berre, D Loeuille, L Peyrin-Biroulet
Clinical Gastroenterology and Hepatology 17 (4), 794-796, 2019
372019
Impact of inflammatory bowel diseases on working life: a French nationwide survey
C Le Berre, L Peyrin-Biroulet, A Buisson, A Olympie, MH Ravel, ...
Digestive and Liver Disease 51 (7), 961-966, 2019
362019
VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases in a French cohort: the VALIDate study
C Le Berre, M Flamant, G Bouguen, L Siproudhis, M Dewitte, N Dib, ...
Journal of Crohn's and Colitis 14 (11), 1512-1523, 2020
302020
Evolving short-and long-term goals of management of inflammatory bowel diseases: getting it right, making it last
C Le Berre, A Ricciuto, L Peyrin-Biroulet, D Turner
Gastroenterology 162 (5), 1424-1438, 2022
292022
A magnetic resonance imaging index to predict Crohn’s disease postoperative recurrence: the MONITOR index
M Schaefer, V Laurent, A Grandmougin, L Vuitton, A Bourreille, A Luc, ...
Clinical Gastroenterology and Hepatology 20 (5), e1040-e1049, 2022
202022
Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease
V Haghnejad, C Le Berre, Y Dominique, C Zallot, F Guillemin, ...
Digestive and Liver Disease 52 (3), 281-288, 2020
192020
Multi-expert annotation of Crohn’s disease images of the small bowel for automatic detection using a convolutional recurrent attention neural network
A de Maissin, R Vallée, M Flamant, M Fondain-Bossiere, C Le Berre, ...
Endoscopy International Open 9 (07), E1136-E1144, 2021
152021
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study
M Fumery, A Defrance, X Roblin, R Altwegg, B Caron, X Hébuterne, ...
Alimentary Pharmacology & Therapeutics 57 (4), 426-434, 2023
102023
Crohn’s-like acute severe colitis associated with Hermansky-Pudlak syndrome: a case report
P Girot, C Le Berre, A De Maissin, M Freyssinet, C Trang-Poisson, ...
World journal of gastroenterology 25 (8), 1031, 2019
102019
Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID
A Amiot, D Laharie, G Malamut, M Serrero, F Poullenot, L Peyrin-Biroulet, ...
Digestive and Liver Disease 54 (9), 1162-1167, 2022
82022
T cells show preferential adhesion to enteric neural cells in culture and are close to neural cells in the myenteric ganglia of Crohn's patients
J Pabois, T Durand, C Le Berre, J Gonzales, M Neunlist, A Bourreille, ...
Journal of Neuroimmunology 349, 577422, 2020
72020
Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations
C Le Berre, L Loy, S Lönnfors, L Avedano, D Piovani
World Journal of Gastroenterology 26 (29), 4343, 2020
72020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20